News
Hosted on MSN10mon
Brain Edema Risk May Be Lower With Modified Donanemab Dosing - MSN
An alternate dosing plan for the anti-amyloid drug donanemab (Kisunla) reduced the risk of brain edema and effusion but still maintained sufficient amyloid reduction in early Alzheimer's disease ...
Posterior reversible encephalopathy syndrome (PRES) is neurological disorder characterized by swelling and inflammation in the brain. Learn about symptoms, potential causes, treatment, and outlook.
Source: Maiwall R, et al. Preemptive administration of continuous renal replacement therapy in patients with acute liver failure with cerebral edema improves outcomes: A randomized controlled trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results